Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain-Healthy diet tested as ADHD treatment for kids

NCT ID NCT07686458

Disease control Sponsor: American University of Beirut Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests whether the MIND diet, a brain-healthy eating plan rich in vegetables, berries, nuts, and fish, can reduce ADHD symptoms in children aged 6 to 12 who are not taking medication. Over 12 weeks, half the children follow the MIND diet while the other half receive standard dietary advice. Researchers measure changes in attention, hyperactivity, and impulsivity using parent and teacher reports, along with tests of thinking skills.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay)
What this could lead to
If effective, the MIND diet could offer a safe, non-drug way to help manage ADHD symptoms in children, potentially reducing the need for medication.
What could go wrong
This is a small, early-stage trial with 158 children, and dietary changes can be hard to maintain. Results may not apply to all children or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 158 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Aug 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 12 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 6 to 12 years at the time of enrollment * Clinical diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) based on DSM-5 diagnostic criteria * Not currently receiving pharmacological treatment for ADHD * Child and caregiver willing to participate in the study procedures for the full 12-week intervention period Exclusion Criteria: Current use of stimulant or non-stimulant pharmacological treatment for ADHD * Presence of medical conditions requiring specialized dietary restrictions (e.g., severe food allergies, metabolic disorders, or medically prescribed diets) * Severe neurological or developmental disorders that may interfere with participation or study assessments * Serious chronic medical illnesses that may affect growth, nutrition, or participation in dietary interventions * Inability of caregiver to comply with study procedures or dietary monitoring requirements

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHD

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.